Rubayath Mohsen leads Business Development & Technology Transfer at The Lundquist Institute (TLI), overseeing commercialization efforts of TLI's 800+ patents & patent applications within the life sciences and med devices sectors. She is responsible for patent strategy, license negotiations and fostering alliances with industry and community partners to advance TLI's mission in translating science into commercialized products. She also supports start-up formation and works in partnership with TLI’s on-campus incubator – BiolabsLA, to further advance innovation and entrepreneurship at TLI.

Prior to joining TLI, Rubayath held the Technology Transfer Manager position at The Rockefeller University in New York where she drafted, negotiated, executed and managed all Tech Transfer contracts for the office with both industry and academia to help facilitate research and technology commercialization. She also carried out technology marketing activities and managed compliance with regard to reporting requirements for federal research sponsors.

Rubayath's journey in Technology Transfer commenced as a Marketing Analyst at the Johns Hopkins Tech Transfer office. Subsequently, she contributed to Columbia Tech Ventures, where she supported their industry outreach efforts as part of their Technology Marketing team.

Rubayath holds a MSc. in Biotechnology from Johns Hopkins University where she studied radio-sensitizing factors in Glioblastoma cancer stem cells in mouse models. She also earned a BSc. in Biomedical Engineering from Boston University where her research focused on developing a point-of-care sepsis diagnostic chip.